US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ION Geophysical

0.3450

0.0000

Volume:- -

Turnover:315.77K

Market Cap:10.21M

PE:-0.17

High:0.3450

Open:0.3450

Low:0.3450

Close:0.3450

52wk High:2.67

52wk Low:0.3000

Shares:29.58M

Float Shares:22.53M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.0886

EPS(LYR):-2.6083

ROE:78.57%

ROA:-3.86%

PB:-0.15

PE(LYR):-0.13

Loading ...

Overview Company News Filings

Sonnet BioTherapeutics Selected for Poster Presentation at the 2025 AACR IO Conference

IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate

IO Biotech Completes Enrollment in Phase 2 Trial of Cancer Vaccine to Treat Resectable Melanoma

MT Newswires Live

IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer

Press Release: IO Biotech secures up to EUR57.5 million in debt financing from the European Investment Bank

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"IO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IO\",,,,,undefined,":{"symbol":"IO","market":"US","secType":"STK","nameCN":"ION Geophysical","latestPrice":0.345,"timestamp":1652904000000,"preClose":0.345,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":22530221,"shares":29579991,"eps":-2.088625,"marketStatus":"Halted","change":0,"latestTime":"02-09 17:02:26 EST","open":0.345,"high":0.345,"low":0.345,"amount":315765.418528,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.088625,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770685200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":670568400000,"exchange":"NYSE","adjPreClose":0.345,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IO\",,,,,undefined,":{"symbol":"IO","floatShares":22530221,"roa":"-3.86%","roe":"78.57%","lyrEps":-2.608253,"shares":29579991,"dividePrice":0,"high":0.345,"amplitude":0,"preClose":0.345,"low":0.345,"week52Low":0.3,"pbRate":"-0.15","psRate":"0.10","week52High":2.67,"institutionHeld":0.612,"latestPrice":0.345,"eps":-2.088625,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.088625,"open":0.345,"prevYearClose":0.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-11-03","symbol":"IO","fiscalQuarterEnding":"2021/09","expectedEps":-0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1635912000000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2021-08-11","symbol":"IO","fiscalQuarterEnding":"2021/06","expectedEps":-0.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1628654400000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2021-05-05","symbol":"IO","fiscalQuarterEnding":"2021/03","expectedEps":-0.61,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1620187200000,"reportTimeType":"post","actualEps":-0.95},{"market":"US","date":"2021-02-10","symbol":"IO","fiscalQuarterEnding":"2020/12","expectedEps":-0.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1612933200000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2020-11-04","symbol":"IO","fiscalQuarterEnding":"2020/09","expectedEps":-0.52,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1604466000000,"reportTimeType":"post","actualEps":-1.16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IO","date":"2022-05-18","current":-0.16518,"percent":0.995981,"low":-11.452533,"twenty":-5.477091,"median":-1.689569,"eighty":-0.889279,"high":-0.221093,"avg":-2.910806,"sd":2.496307,"marketCap":10935722},"quantilePoints":[{"date":"2021-02-11","current":-1.378441,"twenty":-5.554009,"median":-1.619205,"eighty":-0.365249,"marketCap":53184371},{"date":"2021-02-19","current":-1.578473,"twenty":-5.554009,"median":-1.682646,"eighty":-0.37263,"marketCap":58758675},{"date":"2021-02-26","current":-1.515721,"twenty":-5.554009,"median":-1.682646,"eighty":-0.37481,"marketCap":56422703},{"date":"2021-03-05","current":-1.26914,"twenty":-5.554009,"median":-1.689569,"eighty":-0.379537,"marketCap":47243755},{"date":"2021-03-12","current":-1.543946,"twenty":-5.554009,"median":-1.682646,"eighty":-0.381474,"marketCap":57473388},{"date":"2021-03-19","current":-1.4378,"twenty":-5.554009,"median":-1.689569,"eighty":-0.386967,"marketCap":53522093},{"date":"2021-03-26","current":-1.051813,"twenty":-5.554009,"median":-1.682646,"eighty":-0.392342,"marketCap":39153746},{"date":"2021-04-01","current":-1.032514,"twenty":-5.554009,"median":-1.682646,"eighty":-0.399785,"marketCap":38435328},{"date":"2021-04-09","current":-1.28823,"twenty":-5.554009,"median":-1.689569,"eighty":-0.410872,"marketCap":47954358},{"date":"2021-04-16","current":-1.066288,"twenty":-5.554009,"median":-1.689569,"eighty":-0.427933,"marketCap":39692559},{"date":"2021-04-23","current":-1.659438,"twenty":-5.554009,"median":-1.689569,"eighty":-0.430933,"marketCap":61772589},{"date":"2021-04-30","current":-1.760245,"twenty":-5.554009,"median":-1.72403,"eighty":-0.435101,"marketCap":65525129},{"date":"2021-05-07","current":-1.445854,"twenty":-5.554009,"median":-1.731785,"eighty":-0.440865,"marketCap":60906618},{"date":"2021-05-14","current":-1.224263,"twenty":-5.554009,"median":-1.731785,"eighty":-0.454494,"marketCap":51572060},{"date":"2021-05-21","current":-1.333694,"twenty":-5.554009,"median":-1.731785,"eighty":-0.461944,"marketCap":56181853},{"date":"2021-05-28","current":-1.347373,"twenty":-5.554009,"median":-1.731785,"eighty":-0.475982,"marketCap":56758077},{"date":"2021-06-04","current":-1.566235,"twenty":-5.554009,"median":-1.731785,"eighty":-0.482588,"marketCap":65977664},{"date":"2021-06-11","current":-1.491001,"twenty":-5.554009,"median":-1.731785,"eighty":-0.493862,"marketCap":62808431},{"date":"2021-06-18","current":-1.463643,"twenty":-5.554009,"median":-1.731785,"eighty":-0.519923,"marketCap":61655982},{"date":"2021-06-25","current":-1.50468,"twenty":-5.554009,"median":-1.736982,"eighty":-0.545691,"marketCap":63384655},{"date":"2021-07-02","current":-1.436286,"twenty":-5.554009,"median":-1.748614,"eighty":-0.583398,"marketCap":60503534},{"date":"2021-07-09","current":-1.238266,"twenty":-5.554009,"median":-1.748614,"eighty":-0.593204,"marketCap":52161961},{"date":"2021-07-16","current":-1.076447,"twenty":-5.554009,"median":-1.748614,"eighty":-0.606221,"marketCap":45345341},{"date":"2021-07-23","current":-1.020162,"twenty":-5.554009,"median":-1.748614,"eighty":-0.664034,"marketCap":42974343},{"date":"2021-07-30","current":-1.020162,"twenty":-5.554009,"median":-1.748614,"eighty":-0.723078,"marketCap":42974343},{"date":"2021-08-06","current":-0.963878,"twenty":-5.554009,"median":-1.748614,"eighty":-0.729965,"marketCap":40603344},{"date":"2021-08-13","current":-0.632023,"twenty":-5.554009,"median":-1.748614,"eighty":-0.738346,"marketCap":38232346},{"date":"2021-08-20","current":-0.504639,"twenty":-5.554009,"median":-1.748614,"eighty":-0.738346,"marketCap":30526602},{"date":"2021-08-27","current":-0.57813,"twenty":-5.554009,"median":-1.771568,"eighty":-0.747043,"marketCap":34972224},{"date":"2021-09-03","current":-0.641822,"twenty":-5.554009,"median":-1.771568,"eighty":-0.747043,"marketCap":38825096},{"date":"2021-09-10","current":-0.617325,"twenty":-5.554009,"median":-1.771568,"eighty":-0.747043,"marketCap":37343222},{"date":"2021-09-17","current":-0.774106,"twenty":-5.554009,"median":-1.771568,"eighty":-0.772977,"marketCap":46827215},{"date":"2021-09-24","current":-0.65652,"twenty":-5.554009,"median":-1.771568,"eighty":-0.772977,"marketCap":39714220},{"date":"2021-10-01","current":-0.651621,"twenty":-5.554009,"median":-1.771568,"eighty":-0.772977,"marketCap":39417845},{"date":"2021-10-08","current":-0.65652,"twenty":-5.554009,"median":-1.771568,"eighty":-0.772977,"marketCap":39714220},{"date":"2021-10-15","current":-0.690816,"twenty":-5.554009,"median":-1.771568,"eighty":-0.772977,"marketCap":41788843},{"date":"2021-10-22","current":-1.107265,"twenty":-5.554009,"median":-1.771568,"eighty":-0.781917,"marketCap":66980700},{"date":"2021-10-29","current":-0.940686,"twenty":-5.554009,"median":-1.771568,"eighty":-0.81516,"marketCap":56903957},{"date":"2021-11-05","current":-1.009277,"twenty":-5.554009,"median":-1.771568,"eighty":-0.846684,"marketCap":61053204},{"date":"2021-11-12","current":-1.275848,"twenty":-5.554009,"median":-1.771568,"eighty":-0.858362,"marketCap":56568546},{"date":"2021-11-19","current":-1.095492,"twenty":-5.554009,"median":-1.771568,"eighty":-0.871209,"marketCap":48571945},{"date":"2021-11-26","current":-1.168971,"twenty":-5.554009,"median":-1.771568,"eighty":-0.880329,"marketCap":51829820},{"date":"2021-12-03","current":-1.022014,"twenty":-5.554009,"median":-1.771568,"eighty":-0.888657,"marketCap":45314071},{"date":"2021-12-10","current":-1.035374,"twenty":-5.554009,"median":-1.771568,"eighty":-0.905076,"marketCap":45906412},{"date":"2021-12-17","current":-0.921817,"twenty":-5.554009,"median":-1.771568,"eighty":-0.910281,"marketCap":40871515},{"date":"2021-12-23","current":-0.688023,"twenty":-5.554009,"median":-1.771568,"eighty":-0.910281,"marketCap":30505551},{"date":"2021-12-31","current":-0.60192,"twenty":-5.554009,"median":-1.771568,"eighty":-0.910281,"marketCap":26687914},{"date":"2022-01-07","current":-0.600584,"twenty":-5.554009,"median":-1.760245,"eighty":-0.909156,"marketCap":26628680},{"date":"2022-01-14","current":-0.574866,"twenty":-5.554009,"median":-1.760245,"eighty":-0.909156,"marketCap":25488424},{"date":"2022-01-21","current":-0.560772,"twenty":-5.554009,"median":-1.760245,"eighty":-0.909156,"marketCap":24863505},{"date":"2022-01-28","current":-0.340671,"twenty":-5.554009,"median":-1.760245,"eighty":-0.909156,"marketCap":15104690},{"date":"2022-02-04","current":-0.33132,"twenty":-5.554009,"median":-1.760245,"eighty":-0.909156,"marketCap":14690051},{"date":"2022-02-11","current":-0.338801,"twenty":-5.554009,"median":-1.760245,"eighty":-0.909156,"marketCap":15021762},{"date":"2022-02-18","current":-0.334326,"twenty":-5.554009,"median":-1.760245,"eighty":-0.909156,"marketCap":14823328},{"date":"2022-02-25","current":-0.423167,"twenty":-5.554009,"median":-1.760245,"eighty":-0.909156,"marketCap":18762394},{"date":"2022-03-04","current":-0.357638,"twenty":-5.554009,"median":-1.760245,"eighty":-0.909156,"marketCap":15856963},{"date":"2022-03-11","current":-0.78822,"twenty":-5.554009,"median":-1.760245,"eighty":-0.910598,"marketCap":34948107},{"date":"2022-03-18","current":-0.634584,"twenty":-5.554009,"median":-1.760245,"eighty":-0.910598,"marketCap":28136188},{"date":"2022-03-25","current":-0.721422,"twenty":-5.554009,"median":-1.760245,"eighty":-0.910598,"marketCap":31986403},{"date":"2022-04-01","current":-0.582481,"twenty":-5.554009,"median":-1.760245,"eighty":-0.910598,"marketCap":25826058},{"date":"2022-04-08","current":-0.555161,"twenty":-5.554009,"median":-1.760245,"eighty":-0.910598,"marketCap":24614721},{"date":"2022-04-14","current":-0.282203,"twenty":-5.554009,"median":-1.760245,"eighty":-0.910598,"marketCap":12512336},{"date":"2022-04-22","current":-0.434914,"twenty":-5.554009,"median":-1.760245,"eighty":-0.910598,"marketCap":19283196},{"date":"2022-04-29","current":-0.313559,"twenty":-5.554009,"median":-1.760245,"eighty":-0.910598,"marketCap":13902595},{"date":"2022-05-06","current":-0.256852,"twenty":-5.554009,"median":-1.726587,"eighty":-0.907855,"marketCap":11388296},{"date":"2022-05-13","current":-0.22236,"twenty":-5.512747,"median":-1.690456,"eighty":-0.904678,"marketCap":9859011},{"date":"2022-05-18","current":-0.246644,"twenty":-5.477091,"median":-1.689569,"eighty":-0.889279,"marketCap":10935722}],"updateTime":1770674546358},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512638991","title":"Sonnet BioTherapeutics Selected for Poster Presentation at the 2025 AACR IO Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2512638991","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512638991?lang=en_us&edition=fundamental","pubTime":"2025-02-18 22:15","pubTimestamp":1739888100,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., Feb.  18, 2025  (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic dr","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/18/3027970/0/en/Sonnet-BioTherapeutics-Selected-for-Poster-Presentation-at-the-2025-AACR-IO-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SONN","BK4563","BK4007","BK4179","PROC","IO","BK4139"],"gpt_icon":0},{"id":"2508456058","title":"IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2508456058","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508456058?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:05","pubTimestamp":1738674300,"startTime":"0","endTime":"0","summary":"–Submission of Investigational New Drug Application (IND) to US FDA expected in 2025–  NEW YORK, Feb.  04, 2025  (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical compa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/04/3020277/0/en/IO-Biotech-Announces-Publication-of-Preclinical-Data-Investigating-Immune-Modulatory-Effects-of-IO112-an-Arginase-1-Targeting-Therapeutic-Cancer-Vaccine-Candidate.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B12V2V27.USD","LU2039709279.SGD","LU1023057109.AUD","BK4179","IE00BYTNYN87.SGD","IO","BK4535","BK4563","BK4552","IOBT","LU0359202008.SGD","BK4509","BK4108","TME","BK4548","BK4139","IE00BYQNZ168.SGD","BK4531","SG9999011746.SGD","01698","BK4571","LU0359201612.USD","BK4526","BK4565"],"gpt_icon":0},{"id":"2502027888","title":"IO Biotech Completes Enrollment in Phase 2 Trial of Cancer Vaccine to Treat Resectable Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2502027888","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502027888?lang=en_us&edition=fundamental","pubTime":"2025-01-10 05:24","pubTimestamp":1736457877,"startTime":"0","endTime":"0","summary":"IO Biotech  said Thursday it completed enrollment ahead of schedule in a phase 2 trial of its cancer vaccine candidate IO102-IO103 combined with Merck's  Keytruda to treat people with resectable melanoma or squamous cell carcinoma of the head and neck.Initial data is expected this year, the company said.The trial has enrolled 93 people in the US, Europe and Australia, the company added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1934455863.HKD","LU0965509010.AUD","BK4179","LU1989772840.SGD","IOBT","LU0070302665.USD","BK4534","LU0234572021.USD","LU0106261372.USD","SG9999001176.USD","LU0006306889.USD","IE0002141913.USD","LU0211331839.USD","LU1066051225.USD","LU1093756325.SGD","LU1989771016.USD","LU2361045086.USD","LU1037948897.HKD","LU1116320901.HKD","IE00B1BXHZ80.USD","LU1066051498.USD","IE0009355771.USD","IE00B2B36J28.USD","LU1934455277.USD","LU1941712264.USD","LU2089984988.USD","MRK","SG9999002224.SGD","LU0965509283.SGD","IO","LU0861579265.USD","IE00BBT3K403.USD","LU2361044865.SGD","LU1941712348.USD","LU1037948541.HKD","LU1585245621.USD","LU1023059063.AUD","SG9999001440.SGD","LU1917777945.USD","LU0122379950.USD","LU1974910355.USD","LU0985320562.USD","LU0208291251.USD","LU1989772923.USD","SG9999014575.USD","IE00BLSP4452.SGD","LU0238689110.USD","SG9999014559.SGD","IE00BJT1NW94.SGD","BK4559"],"gpt_icon":0},{"id":"2502110280","title":"IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2502110280","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502110280?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:05","pubTimestamp":1736427900,"startTime":"0","endTime":"0","summary":"-- Enrollment Completed Ahead of Schedule -- -- Initial Data Expected in 2025 -- NEW YORK, Jan.  09, 2025  (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company dev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/09/3007033/0/en/IO-Biotech-Completes-Enrollment-in-Phase-2-Trial-of-its-Investigational-Off-the-shelf-Therapeutic-Cancer-Vaccine-IO102-IO103-as-Neoadjuvant-Adjuvant-Treatment-for-Patients-with-Res.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","LU1571399168.USD","LU1989771016.USD","LU1791807156.HKD","IE00BN8TJ469.HKD","LU1983299246.USD","LU0203345920.USD","SG9999015358.SGD","BK4588","IE00BLSP4239.USD","LU0265550359.USD","LU2023250843.SGD","LU2361044949.HKD","LU1585245621.USD","IE00B1BXHZ80.USD","BK4516","01698","LU0985320562.USD","LU1941712348.USD","BK4108","DFS","SGXZ57979304.SGD","BK4531","LU0965509101.SGD","LU1430594728.SGD","LU2360107671.USD","BK4559","LU2106854487.HKD","LU2361045086.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU0359202008.SGD","LU1699723380.USD","IE00BJT1NW94.SGD","IE00BYQNZ168.SGD","LU0006306889.USD","BK4166","IO","TME","BK4548","IOBT","IE0002141913.USD","LU1917777945.USD","LU1093756325.SGD","LU0106831901.USD","LU1023057109.AUD","BK4552","BK4533","IE00B2B36J28.USD","LU1934455863.HKD"],"gpt_icon":0},{"id":"2492744813","title":"Press Release: IO Biotech secures up to EUR57.5 million in debt financing from the European Investment Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2492744813","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492744813?lang=en_us&edition=fundamental","pubTime":"2024-12-20 21:05","pubTimestamp":1734699900,"startTime":"0","endTime":"0","summary":"-- Funds expected to be used to advance IO Biotech's immune-modulating. therapeutic cancer vaccines, including potential BLA submission for. -- Commitment is part of the European Investment Bank's strategy to support. biotech companies with cutting-edge expertise in therapeutic areas such. -- Debt facility expected to extend company's cash runway into the second. Amy Sullivan, Chief Financial Officer of IO Biotech, commented, \"The support from the EIB, which is provided on favorable terms, will help fund the continued development and pre-commercialization of IO102-IO103 and other therapeutic cancer vaccine candidates generated from our T-Win platform. We expect that the capital drawn from the three committed tranches of the EIB debt facility will extend our cash runway into the second quarter of 2026.\". Van Lanschot Kempen served as financial advisor to the company and Kromann Reumert and Sidley A","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TME","IOBT","R","LU0106261372.USD","IE00B2B36J28.USD","LU0965509101.SGD","BK4535","MRK","LU1116320901.HKD","LU0965509010.AUD","LU2089984988.USD","BK4550","LU1934455863.HKD","IE00BLSP4239.USD","BK4232","LU2361045086.USD","LU0208291251.USD","SG9999014567.USD","IE00BSNM7G36.USD","LU1116320737.USD","BK4565","IE00BN8TJ469.HKD","SG9999015341.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1037948897.HKD","LU1941712348.USD","BK4534","LU2361044949.HKD","LU1974910355.USD","IO","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU1941712264.USD","LU0234572021.USD","LU1989772840.SGD","LU1037948541.HKD","SG9999001176.USD","LU1430594728.SGD","LU0070302665.USD","LU0006306889.USD","BK4588","LU2324357040.USD","LU0203347892.USD","LU1066053197.SGD","LU2468319806.SGD","SG9999015358.SGD","BK4571","01698","BK4531"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}